AMBEV S.A. current report, Q1 FY2022

Business Context and Reporting Period

This Form 6-K filing by Ambev S.A. covers the month of January 2022, with the report signed on February 9, 2022. The filing serves as a compliance report under Article 11 of CVM Instruction # 358/2002, detailing transactions involving the company's own securities and derivatives.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on treasury share transactions and derivative positions.

  • Treasury Share Acquisition: Ambev S.A. purchased 8,309 common shares directly from the company under a share acquisition plan.
  • Transaction Volume: The total volume for the share purchase was R$ 124,718.09.
  • Average Price: The purchase price was R$ 15.01 per share.
  • Derivatives: No transactions occurred for swaps referenced in shares or ADRs for the subsidiary Ambev Luxembourg S.à.r.l.

Material Changes Versus Prior Period

The filing reports a change in the company's treasury share position:

  • Initial Balance: 5,782,513 common shares held in treasury.
  • Final Balance: 5,790,822 common shares held in treasury.
  • Net Change: An increase of 8,309 shares due to the buyback activity in January 2022.

No other material changes regarding securities or derivatives were reported for the subsidiary Ambev Luxembourg S.à.r.l., which maintained a zero balance for swaps referenced in shares and ADRs.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, financial guidance, outlook, risk factors, or contingencies. The document is strictly a regulatory disclosure of specific securities transactions required by Brazilian securities regulations (CVM Instruction # 358/2002).

Important Facts for Investor Verification

  • Verify the total number of treasury shares held by Ambev S.A. as of the end of January 2022 (5,790,822).
  • Confirm the execution of the share acquisition plan, noting the purchase of 8,309 shares at R$ 15.01 each.
  • Note that no derivative transactions (swaps) were executed by the subsidiary Ambev Luxembourg S.à.r.l. during this period.
  • Understand that this filing does not contain quarterly or annual financial results; refer to Form 20-F for comprehensive financial data.